RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - IMMUNITA' INNATA E MALATTIA CELIACA
• 2 - Nuove strategie immunomodulatorie nella Malattia di Graves: ruolo delle chemochine e delle cellule T regolatorie
• 3 - MECCANISMI MUCOSALI DI DANNO E RIPARAZIONE NELLE MALATTIE INFIAMMATORIE CRONICHE INTESTINALI (MICI)
• 4 - MALATTIE INFIAMMATORIE INTESTINALI DEL BAMBINO: STUDIO DELLA ESPRESSIONE DI GENI IN RAPPORTO ALLA IMMUNITA' INNATA, ALLA IMMUNITA' RITARDATA E ALLA RISPOSTA ALLA TERAPIA IMMUNOMODULANTE.
• 5 - Il fenomeno della cross-presentazione ed i segnali immunomodulatori nella genesi di patologie infettive ed autoimmuni
• 6 - Il fattore di trascrizione NF-kB nella regolazione del differenziamento ed apoptosi del sistema immune.
• 7 - RUOLO DI AGENTI INFETTIVI E DELL'INFIAMMAZIONE CORRELATA ALLA RISPOSTA IMMUNITARIA ADATTATIVA NELLA PATOGENESI DELLE SINDROMI CORONARICHE ACUTE
• 8 - Identificazione, analisi molecolare ed attività funzionale di recettori di membrana e fattori citoplasmatici coinvolti nella crescita e differenziamento di cellule di leucemia linfatica cronica B: impatto sulla prognosi clinica.
• 9 - Immunità umorale nella sclerosi multipla: attivazione dei linfociti B e demielinizzazione
• 10 - Modulazione dei meccanismi di apoptosi in corso di risposta immunitaria/infiammatoria: studio delle interazioni tra citochine della famiglia del TNF per la caratterizzazione di meccanismi molecolari e cellulari funzionali alla identificazione di nuovi target per la terapia di malattie croniche degenerative.

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • MICROBIOLOGIA E MICROBIOLOGIA CLINICA
  • MEDICINA INTERNA
  • GASTROENTEROLOGIA
  • MALATTIE DEL SANGUE
  • CHIRURGIA GENERALE

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
• HUMAN NECESSITIES
  • MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (bringing into special physical form A61J [N: mechanical aspects]; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; compounds per se C01, C07, C08, C12N; soap compositions C11D; micro-organisms per se C12N) [C0203]

Classificazione geografica

• Regione: Toscana

Bibliografia

1. Shanahan F &.O'Mahony J. The Mycobacteria story in Crohn's disease. Am J Gastroenterol 100:1537, 2005.
2. Cocito C et al. Paratuberculosis. Clin Microbiol Rev 1994;7: 328–45
3. Clarke CJ. The pathology and pathogenesis of paratuberculosis in ruminants and other species. J Comp Pathol 116:217, 1997
4. Whittington RJ et al. Molecular epidemiology of Mycobacterium avium subsp. paratuberculosis: IS900 restriction fragment length polymorphism and IS1311 polymorphism analyses of isolates from animals and a human in Australia. J Clin Microbiol 38:3240, 2000
5. Ghadiali AH et al. Mycobacterium avium subsp. paratuberculosis strains isolated from Crohn's disease patients and animal species exhibit similar polymorphic locus patterns. J Clin Microbiol 42:5345, 2004
6. Manning EJ, Collins MT. Mycobacterium avium subspecies paratuberculosis: Pathogen, pathogenicity and diagnosis. Rev Sci Technol 20:133, 2001
7. Grant IR et al. Incidence of Mycobacterium paratuberculosis in bulk raw and commercially pasteurized cows' milk from approved dairy processing establishments in the United Kingdom. Appl Environ Microbiol 68:2428, 2002
8. Hermon-Taylor J et al. Causation of Crohn's disease by Mycobacterium avium subspecies paratuberculosis. Can J Gastroenterol 14:521, 2000
9. Sechi LA et al. Identification of Mycobacterium avium subp. paratuberculosis in biopsies from patients with Crohn's disease identified by in situ hybridization. J Clin Microbiol 39:4514, 2001
10. Naser SA et al. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 364:1039, 2004
11. Bull TJ et al. Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease. J Clin Microbiol 41:2915, 2003
12. Schwartz D et al. Use of short-term culture for identification of Mycobacterium avium subsp. paratuberculosis in tissue from Crohn's disease patients. Clin Microbiol Infect 6:303, 2000
13. Autschbach F et al. High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease. Gut 11:116, 2005
14. Bernstein CN et al. Study of animal-borne infections in the mucosas of patients with inflammatory bowel disease and population-based controls. J Clin Microbiol 41:4986, 2003
15. Sechi LA et al. Detection and Isolation of Mycobacterium avium subspecies paratuberculosis from intestinal mucosal biopsies of patients with and without Crohn's disease in Sardinia. Am J Gastroenterol 100:1529, 2005
16. Gledhill A, Dixon MF. Crohn's-like reaction in diverticular disease. Gut 42:392, 1998
17. Zeitz M. Pathogenesis of inflammatory bowel disease. Digestion 58 (suppl 1):59, 1997
18. Fiocchi C. Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 115:182, 1998
19. Breese E, et al. Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology 78:127, 1993
20. Fuss IJ, et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 157:1261, 1996
21. Parrello T, et al. Up-regulation of the IL-12 receptor beta 2 chain in Crohn’s disease. J Immunol 165:7234, 2000
22. Stallmach A, et al. Increased expression of IL-12 receptor b2 mRNA in lamina propria mononuclear cells of patients with active Crohn’s disease. Int J Colorectal Dis 17:303, 2002
23. Monteleone G, et al. Interleukin 12 is expressed and actively released by Crohn’s disease intestinal lamina propria mononuclear cells. Gastroenterology 112:1169, 1997
24. Parronchi P, et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn’s disease. Am J Pathol 150:823, 1997
25. Berrebi D, et al. Interleukin-12 expression is focally enhanced in the gastric mucosa of pediatric patients with Crohn’s disease. Am J Pathol 152:667, 1998
26. Sandborn WJ, & Hanauer SB. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results and safety. Inflamm Bow Dis 5:119, 1999
27. Plevy, SE, et al. A role for TNF-a and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 159:6276, 1997
28. Lowes J, Jewell D. The immunology of inflammatory bowel disease. Springer Semin Immunopathol 12:251, 1990
29. Schreiber S, et al. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology 101:1020, 1991.
30. Burgio V, et al. Peripheral monocyte and naive T-cell recruitment activation in Crohn's disease. Gastroenterology 109:1029, 1995
31. Pallone F, et al. Activation of peripheral blood and lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by expression of early activation antigens. Gut 28:745, 1987
32. Franz J, et al. Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis. Eur J Immunol 28:2661, 1998
33. Blaschke V, et al. Expression of the CD4+ cell-specific chemoattractant interleukin-16 in Mycosis fungoides. J Invest Dermatol 113:658, 1999
34. Center D, et al. Interleukin-16 and its function as a CD4 ligand. Immunol Today 17:476, 1996
35. Cruikshank W, et al. Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biological function with CD4 expression. Proc Natl Acad Sci USA 91:5109, 1994
36. Rumsaeng V, et al. Human mast cells produce the CD4+ T lymphocyte chemoattractant factor IL16. J Immunol 159:2904, 1997
37. Lim K, et al. Human eosinophils elaborate the lymphocyte chemoattractants IL-16 (lymphocyte chemoattractant factor) and RANTES. J Immunol 156:2566, 1996
38. Laberge S, et al. Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis. J Allergy Clin Immunol 102:645, 1998
39. Laberge S, et al. Phenotype of IL-16-producing cells in bronchial mucosa: Evidence for the human eosinophil and mast cell as sources of IL-16 in asthma. Int Arch Allergy Immunol 119:120, 1999
40. Sanderson JD. Mycobacteria in Crohn's disease. BMJ 306:1131, 1993
41. Selby WS. Mycobacterium avium subspecies paratuberculosis bacteraemia in patients with inflammatory bowel disease. Lancet 364:1013, 2004
42. Sartor RB. Does Mycobacterium avium subspecies paratuberculosis cause Crohn's disease? Gut 54:896, 2005
43. Hirata I, et al. Immunoelectron microscopic localization of HLA-DR antigen in control small intestine and colon and in inflammatory bowel disease. Dig Dis Sci 31:1317, 1986
44. Geboes K, et al. histocompatibility class II expression on the small intestinal nervous system in Crohn's disease. Gastroenterology. 103:439, 1992
45. Cornet A, et al. Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease? Proc Natl Acad Sci U S A.98:13306, 2001
46. Cabarrocas J, et al. Role of enteric glia cells in inflammatory bowel disease. Glia. 41:81, 2003
47. Charagundla SR, et al. Diffuse intestinal ganglioneuromatosis mimicking Crohn's disease. AJR Am J Roentgenol. 182:1166, 2004

Parole Chiave

MALATTIA DI CROHN, MYCOBACTERIUM AVIUM PARATUBERCULOSIS (MAP), ENTEROGLIA, LINFOCITI T INTESTINALI, CITOCHINE, CELLULE TH1/TH2, ANTIGENI DI MAP, DIAGNOSI MICROBIOLOGICA, LESIONI INTESTINALI